Press Releases

SAN ANTONIO, Aug. 8, 2019 /PRNewswire/ -- When Americans return to work and school after summer vacation, the fall allergy season will begin to impact many of the nearly 50 million allergy sufferers across the country1. According to the Asthma and Allergy Foundation of America, Americans lost more than 6 million work and school days in 2018, costing abou

GERMANTOWN, Md., Aug. 8, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of

NEW HAVEN, Conn., Aug. 8, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial results for the quarter ended June 30, 2019, and pro

OAKLAND, Calif., Aug. 8, 2019 /PRNewswire/ -- An effort to improve the scheduled cesarean section delivery experience found that changes to preoperative and postoperative processes can lead to reductions in opioid use without increased pain and with faster recovery, according to research from Kaiser Permanente published in the journal Obstetrics & Gynecology.

LOS ANGELES, Aug. 8, 2019 /PRNewswire/ -- "Speak Life," "Share Life," and "Take Flight," are some of the positive messages on a new colorful mural painted by South Los Angeles at-risk middle school and high school students and community artist Moses Ball.

SAN FRANCISCO, Aug. 8, 2019 /PRNewswire/ --  Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2019.Cash and investments in marketable securities at June 30, 2019 were $1.8 billion as compared to

SAN DIEGO, Aug. 8, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage Precision Cancer Medicine™ company, developing drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today announced company highlights and financial results for the second quarter ended

ROCKVILLE, Md., Aug. 8, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve th

REDWOOD CITY, Calif., Aug. 8, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported financial results for the second quarter ended June 30, 2019. Revenue for the second quarter of 2019 was

LA JOLLA, Calif., Aug. 8, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of inn